Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Publication

Integration analysis identifies MYBL1 as a novel immunotherapy biomarker affecting the immune microenvironment in clear cell renal cell carcinoma: Evidence based on machine learning and experiments.

Frontiers in immunology | 2022

Previous studies have identified MYBL1 as a cancer-promoting molecule in numerous types of cancer. Nevertheless, the role of MYBL in renal cancer remains unclear.

Pubmed ID: 36591240 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.

786-O (tool)

RRID:CVCL_1051

Cell line 786-O is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

HK-2 [Human kidney] (tool)

RRID:CVCL_0302

Cell line HK-2 [Human kidney] is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions

About

The SciCrunch Infrastructure was developed as a cooperative data platform to be used by diverse communities in making data more FAIR.

Contact Us

FAIR Data Informatics Lab

University of California, San Diego

9500 Gilman Drive, Mail Code 0608

La Jolla, CA 92093-0608

United States

info

scicrunch.org

About SciCrunch | Privacy Policy | Terms of Service

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Integration analysis identifies MYBL1 as a novel immunotherapy biomarker affecting the immune microenvironment in clear cell renal cell carcinoma: Evidence based on machine learning and experiments.

Research resources used in this publication

Additional research tools detected in this publication

Antibodies used in this publication

Associated grants